Sub-segments

Biotechnology companies by SEC industry code
SegmentCompaniesWith pricesAverage move
Biological Products, (No Diagnostic Substances) (SIC 2836)180163−0.80%
Services-Commercial Physical & Biological Research (SIC 8731)1713−1.17%

Pipeline by phase

  • Phase 2/3 13
  • Phase 3 66
  • Filed 1
  • Approved 32

Companies

Biotechnology companies, most drugs first
CompanyCloseChangeDrugsNext catalyst
GILEAD SCIENCES, INC.GILD165.61Up +6.41 (+4.03%) since 28 Oct14—
AMGEN INCAMGN466.01Up +5.28 (+1.15%) since 29 Oct12—
BIOGEN INC.BIIB253.62Up +3.97 (+1.59%) since 29 Oct10—
INCYTE CORPINCY116.80Down −0.07 (−0.06%) since 28 Oct10—
NEUROCRINE BIOSCIENCES INCNBIX146.38Up +0.85 (+0.58%) since 28 Oct5—
AlvotechALVO, ALVOW4.89Down −0.05 (−1.01%) since 28 Oct4—
ARGENX SEARGX897.85Up +6.09 (+0.68%) since 28 Oct4—
Kodiak Sciences Inc.KOD100.40Up +3.36 (+3.46%) since 28 Oct4—
Revolution Medicines, Inc.RVMD, RVMDW190.27Up +1.55 (+0.82%) since 28 Oct3—
BioNTech SEBNTX89.13Up +1.14 (+1.30%) since 28 Oct2—
DBV Technologies S.A.DBVT, DBVTF10.29Down −0.36 (−3.38%) since 28 Oct2—
Immunocore Holdings plcIMCR31.27Down −1.34 (−4.11%) since 28 Oct2—
Immunovant, Inc.IMVT29.64Up +0.22 (+0.75%) since 28 Oct2—
Invivyd, Inc.IVVD0.60Down −0.01 (−2.37%) since 28 Oct2—
Protara Therapeutics, Inc.TARA2.52Up +0.03 (+1.20%) since 28 Oct2—
Vir Biotechnology, Inc.VIR11.75Down −0.18 (−1.51%) since 28 Oct2—
4D Molecular Therapeutics, Inc.FDMT12.78Down −0.15 (−1.16%) since 28 Oct1—
aTYR PHARMA INCATYR5.37Up +0.23 (+4.56%) since 28 Oct1—
BIOCRYST PHARMACEUTICALS INCBCRX8.52Up +0.15 (+1.79%) since 28 Oct1—
Cabaletta Bio, Inc.CABA1.59Up +0.07 (+4.28%) since 28 Oct1—
Candel Therapeutics, Inc.CADL8.65Down −0.02 (−0.23%) since 28 Oct1—
CG Oncology, Inc.CGON63.47Down −0.49 (−0.77%) since 28 Oct1—
Compass Therapeutics, Inc.CMPX0.76Unchanged 0.00 (−0.54%) since 28 Oct1—
Denali Therapeutics Inc.DNLI19.32Up +0.03 (+0.16%) since 28 Oct1—
Eikon Therapeutics, Inc.EIKN5.35Down −0.19 (−3.43%) since 28 Oct1—
Electra Therapeutics, Inc.ETRA8.64Down −0.34 (−3.79%) since 28 Oct1—
EXELIXIS, INC.EXEL66.20Down −0.08 (−0.12%) since 28 Oct1—
Humacyte, Inc.HUMA0.47Unchanged 0.00 (−0.06%) since 28 Oct1—
ImmunityBio, Inc.IBRX8.74Down −0.07 (−0.79%) since 28 Oct1—
Inhibikase Therapeutics, Inc.IKT1.67Up +0.05 (+3.09%) since 28 Oct1—
Inhibrx Biosciences, Inc.INBX73.65Up +0.36 (+0.49%) since 28 Oct1—
Innate Pharma SAIPHA, IPHYF1.50Down −0.02 (−1.32%) since 28 Oct1—
Krystal Biotech, Inc.KRYS324.55Up +3.13 (+0.97%) since 28 Oct1—
Kyverna Therapeutics, Inc.KYTX5.85Down −0.04 (−0.68%) since 28 Oct1—
LENZ Therapeutics, Inc.LENZ3.49Up +0.28 (+8.72%) since 28 Oct1—
LeonaBio, Inc.LONA4.91Down −0.05 (−1.01%) since 28 Oct1—
Moderna, Inc.MRNA221.72Down −1.04 (−0.47%) since 29 Oct1—
Neumora Therapeutics, Inc.NMRA0.39Unchanged 0.00 (−1.22%) since 28 Oct1—
NOVAVAX INCNVAX10.47Up +0.15 (+1.45%) since 28 Oct1—
Ocugen, Inc.OCGN0.74Down −0.03 (−4.15%) since 28 Oct1—
Relay Therapeutics, Inc.RLAY19.47Down −0.22 (−1.12%) since 28 Oct1—
Scholar Rock Holding CorpSRRK44.18Up +0.93 (+2.15%) since 28 Oct1—
Solid Biosciences Inc.SLDB6.39Down −0.09 (−1.39%) since 28 Oct1—
Tarsus Pharmaceuticals, Inc.TARS74.20Up +2.15 (+2.98%) since 28 Oct1—
TScan Therapeutics, Inc.TCRX0.19Unchanged 0.00 (−2.01%) since 28 Oct1—
Valneva SEVALN5.71Down −0.03 (−0.52%) since 28 Oct1—
Vaxcyte, Inc.PCVX62.61Up +1.15 (+1.87%) since 28 Oct1—
Vor Biopharma Inc.VOR20.91Up +0.26 (+1.26%) since 28 Oct1—
Abpro Holdings, Inc.ABPO, ABPWW—Change: not yet available0—
Absci CorpABSI12.10Up +0.22 (+1.85%) since 28 Oct0—
Acumen Pharmaceuticals, Inc.ABOS2.29Down −0.09 (−3.78%) since 28 Oct0—
Adaptimmune Therapeutics PLCADAPY—Change: not yet available0—
ADAPTIN BIO, INC.APTN—Change: not yet available0—
Adaptive Biotechnologies CorpADPT28.17Down −0.20 (−0.70%) since 28 Oct0—
ADMA BIOLOGICS, INC.ADMA11.75Up +0.47 (+4.17%) since 28 Oct0—
Agentix Corp.AGTX—Change: not yet available0—
AGENUS INCAGEN7.09Down −0.04 (−0.56%) since 28 Oct0—
AgomAb Therapeutics NVAGMB7.95Down −0.01 (−0.13%) since 28 Oct0—
AIM ImmunoTech Inc.AIM0.16Unchanged 0.00 (−2.42%) since 28 Oct0—
Alector, Inc.ALEC2.24Down −0.01 (−0.44%) since 28 Oct0—
Aligos Therapeutics, Inc.ALGS5.03Down −0.14 (−2.71%) since 28 Oct0—
Allogene Therapeutics, Inc.ALLO1.25Down −0.05 (−3.85%) since 28 Oct0—
Alpha Cognition Inc.ACOG9.19Up +0.02 (+0.22%) since 28 Oct0—
ANAVEX LIFE SCIENCES CORP.AVXL1.30Unchanged 0.00 (0.00%) since 28 Oct0—
Armata Pharmaceuticals, Inc.ARMP3.25Down −0.04 (−1.22%) since 28 Oct0—
Artiva Biotherapeutics, Inc.ARTV4.23Down −0.04 (−1.05%) since 28 Oct0—
Atara Biotherapeutics, Inc.ATRA8.53Down −0.13 (−1.50%) since 28 Oct0—
Attovia Therapeutics, Inc.ATTO15.27Down −0.53 (−3.35%) since 28 Oct0—
Aura Biosciences, Inc.AURA6.30Down −0.10 (−1.64%) since 28 Oct0—
Autolus Therapeutics plcAUTL1.58Down −0.05 (−3.07%) since 28 Oct0—
Beam Therapeutics Inc.BEAM28.84Up +0.06 (+0.21%) since 28 Oct0—
BIO-TECHNE CorpTECH72.71Up +0.02 (+0.03%) since 28 Oct0—
bioAffinity Technologies, Inc.BIAF, BIAFW3.03Down −0.11 (−3.50%) since 28 Oct0—
BioAtla, Inc.BCAB—Change: not yet available0—
BioCardia, Inc.BCDA0.93Down −0.02 (−2.26%) since 28 Oct0—
BioStem Technologies, Inc.BSEM1.29Down −0.22 (−14.57%) since 28 Oct0—
Black Diamond Therapeutics, Inc.BDTX1.86Up +0.03 (+1.64%) since 28 Oct0—
Black Hawk Acquisition CorpBKHA, BKHAR, BKHAU5.00Up +0.42 (+9.17%) since 28 Oct0—
BRAINSTORM CELL THERAPEUTICS INC.BCLI—Change: not yet available0—
C4 Therapeutics, Inc.CCCC3.30Down −0.09 (−2.80%) since 28 Oct0—
Calidi Biotherapeutics, Inc.CLDI, CLDWW0.67Down −0.03 (−4.29%) since 28 Oct0—
Cannabis Bioscience International Holdings, Inc.CBIH—Change: not yet available0—
Cardiff Oncology, Inc.CRDF0.91Up +0.01 (+1.60%) since 28 Oct0—
Cardiol Therapeutics Inc.CRDL1.17Unchanged 0.00 (0.00%) since 28 Oct0—
Caribou Biosciences, Inc.CRBU0.45Down −0.04 (−9.07%) since 28 Oct0—
CEL SCI CORPCVM1.50Down −0.10 (−6.25%) since 28 Oct0—
Cellectis S.A.CLLS1.17Down −0.09 (−7.14%) since 28 Oct0—
Century Therapeutics, Inc.IPSC1.46Down −0.04 (−2.67%) since 28 Oct0—
CERO THERAPEUTICS HOLDINGS, INC.CERO, CEROW—Change: not yet available0—
CHAMPIONS ONCOLOGY, INC.CSBR4.81Down −0.11 (−2.24%) since 28 Oct0—
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL376.10Up +2.12 (+0.57%) since 28 Oct0—
COGNITION THERAPEUTICS INCCGTX0.74Down −0.01 (−1.28%) since 28 Oct0—
Coherus Oncology, Inc.CHRS0.90Down −0.26 (−22.55%) since 28 Oct0—
COMPUGEN LTDCGEN2.04Up +0.03 (+1.49%) since 28 Oct0—
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.CELZ0.68Down −0.04 (−5.78%) since 28 Oct0—
CRISPR Therapeutics AGCRSP54.26Up +0.15 (+0.28%) since 28 Oct0—
Cullinan Therapeutics, Inc.CGEM15.45Down −0.11 (−0.71%) since 28 Oct0—
Curative Biotechnology IncCUBT—Change: not yet available0—
CURIS INCCRIS0.55Up +0.09 (+20.81%) since 28 Oct0—
DYADIC INTERNATIONAL INCDYAI0.36Down −0.03 (−8.40%) since 28 Oct0—
Editas Medicine, Inc.EDIT2.93Down −0.02 (−0.68%) since 28 Oct0—
Eloxx Pharmaceuticals, Inc.ELOX13.20Up +0.08 (+0.61%) since 28 Oct0—
ELUTIA INC.ELUT0.81Down −0.03 (−3.13%) since 28 Oct0—
enGene Therapeutics Inc.ENGN, ENGNW1.53Down −0.05 (−3.16%) since 28 Oct0—
Entera Bio Ltd.ENTX3.12Up +0.02 (+0.65%) since 28 Oct0—
Estrella Immunopharma, Inc.ESLA, ESLAW0.73Down −0.09 (−11.32%) since 28 Oct0—
Evaxion A/SEVAX3.08Down −0.03 (−0.96%) since 28 Oct0—
EXOZYMES INC.EXOZ4.11Down −0.11 (−2.72%) since 28 Oct0—
FATE THERAPEUTICS INCFATE2.17Unchanged 0.00 (0.00%) since 28 Oct0—
FENNEC PHARMACEUTICALS INC.FENC10.95Up +0.08 (+0.74%) since 28 Oct0—
FOXO TECHNOLOGIES INC.FOXO, FOXOW—Change: not yet available0—
Genenta Science S.p.A.GNTA0.62Up +0.02 (+2.48%) since 28 Oct0—
Ginkgo Bioworks Holdings, Inc.DNA12.74Down −0.58 (−4.35%) since 28 Oct0—
Green Planet Bio Engineering Co. Ltd.GPLB—Change: not yet available0—
Greenland Mines LtdGRML, GRMLW5.14Down −0.31 (−5.69%) since 28 Oct0—
HALOZYME THERAPEUTICS, INC.HALO131.18Up +1.15 (+0.88%) since 28 Oct0—
Hemab Therapeutics Holdings, Inc.COAG40.42Up +1.92 (+4.99%) since 28 Oct0—
Iambic Therapeutics, Inc.IAM14.28Down −0.50 (−3.38%) since 28 Oct0—
IB Acquisition Corp.IBAC, IBACR10.86Unchanged 0.00 (0.00%) since 23 Oct0—
ICON PLCICLR215.48Up +1.32 (+0.62%) since 28 Oct0—
ImageneBio, Inc.IMA4.05Down −0.15 (−3.57%) since 28 Oct0—
Immatics N.V.IMTX7.31Down −0.04 (−0.54%) since 28 Oct0—
IN8BIO, INC.INAB0.98Down −0.04 (−3.91%) since 28 Oct0—
Inmune Bio, Inc.INMB1.60Up +0.07 (+4.58%) since 28 Oct0—
Instil Bio, Inc.TIL6.83Up +0.04 (+0.52%) since 28 Oct0—
INTENSITY THERAPEUTICS, INC.INTS3.34Down −0.04 (−1.18%) since 28 Oct0—
IOVANCE BIOTHERAPEUTICS, INC.IOVA9.56Down −5.25 (−35.45%) since 28 Oct0—
IQVIA HOLDINGS INC.IQV275.06Down −3.98 (−1.43%) since 28 Oct0—
IRulya Therapeutics Inc.IRLA, QNCX31.62Down −1.33 (−4.05%) since 28 Oct0—
iSpecimen Inc.ISPC0.79Down −0.08 (−9.35%) since 28 Oct0—
Jasper Therapeutics, Inc.JSPR0.53Down −0.01 (−1.26%) since 28 Oct0—
Kalaris Therapeutics, Inc.KLRS2.13Up +0.12 (+5.97%) since 28 Oct0—
Kymera Therapeutics, Inc.KYMR122.60Up +0.09 (+0.07%) since 28 Oct0—
Lexeo Therapeutics, Inc.LXEO3.06Down −0.07 (−2.24%) since 28 Oct0—
Liminatus Pharma, Inc.LIMN, LIMNW2.90Down −0.02 (−0.86%) since 28 Oct0—
Lineage Cell Therapeutics, Inc.LCTX1.03Down −0.01 (−0.96%) since 28 Oct0—
Lycia Therapeutics, Inc.LYCA27.73Up +2.68 (+10.70%) since 28 Oct0—
MAXCYTE, INC.MXCT1.73Up +0.02 (+1.17%) since 28 Oct0—
Maze Therapeutics, Inc.MAZE31.93Up +0.20 (+0.63%) since 28 Oct0—
Medpace Holdings, Inc.MEDP677.56Down −15.12 (−2.18%) since 28 Oct0—
MeiraGTx Holdings plcMGTX9.71Down −0.04 (−0.46%) since 28 Oct0—
MESOBLAST LTDMESO, MEOBF15.67Up +2.28 (+17.03%) since 28 Oct0—
Metagenomi Therapeutics, Inc.MGX0.83Up +0.01 (+1.03%) since 28 Oct0—
MiNK Therapeutics, Inc.INKT10.88Up +0.08 (+0.69%) since 28 Oct0—
MOLECULAR PARTNERS AGMOLN3.53Down −0.18 (−4.88%) since 28 Oct0—
Monte Rosa Therapeutics, Inc.GLUE10.87Up +0.02 (+0.18%) since 28 Oct0—
Mosaic ImmunoEngineering Inc.CPMV—Change: not yet available0—
NRC HEALTHNRC23.49Up +0.02 (+0.09%) since 28 Oct0—
Odyssey Therapeutics, Inc.ODTX19.83Up +0.29 (+1.48%) since 28 Oct0—
OKYO Pharma LtdOKYO1.50Up +0.01 (+0.67%) since 28 Oct0—
OmniAb, Inc.OABI, OABIW5.23Down −0.05 (−0.95%) since 28 Oct0—
OneMedNet CorpONMD, ONMDW4.37Down −0.09 (−2.02%) since 28 Oct0—
Opthea LtdCKDXF, CYVNY, OPTEY—Change: not yet available0—
Outlook Therapeutics, Inc.OTLK0.49Down −0.05 (−9.43%) since 28 Oct0—
PALISADE BIO, INC.PALI1.19Unchanged 0.00 (0.00%) since 28 Oct0—
Passage BIO, Inc.PASG3.52Up +0.19 (+5.71%) since 28 Oct0—
Pelthos Therapeutics Inc.PTHS16.54Up +0.80 (+5.08%) since 28 Oct0—
PharmaCyte Biotech, Inc.PMCB0.33Unchanged 0.00 (−0.78%) since 28 Oct0—
Pluri Inc.PLUR1.20Down −0.03 (−2.44%) since 28 Oct0—
PRECISION BIOSCIENCES INCDTIL7.44Down −0.03 (−0.40%) since 28 Oct0—
Prime Medicine, Inc.PRME5.24Down −0.12 (−2.24%) since 28 Oct0—
PROKIDNEY CORP.PROK1.47Down −0.05 (−3.29%) since 28 Oct0—
Protalix BioTherapeutics, Inc.PLX2.61Up +0.02 (+0.77%) since 28 Oct0—
QIAGEN N.V.QGEN50.34Up +0.01 (+0.02%) since 28 Oct0—
RECURSION PHARMACEUTICALS, INC.RXRX4.24Down −0.11 (−2.53%) since 28 Oct0—
REGENXBIO Inc.RGNX7.41Up +0.17 (+2.35%) since 28 Oct0—
REPLIGEN CORPRGEN188.64Up +3.95 (+2.14%) since 28 Oct0—
Replimune Group, Inc.REPL17.39Up +1.33 (+8.28%) since 28 Oct0—
SAB Biotherapeutics, Inc.SABS, SABSW3.23Up +0.03 (+0.94%) since 28 Oct0—
Sana Biotechnology, Inc.SANA2.72Up +0.09 (+3.42%) since 28 Oct0—
SANGAMO THERAPEUTICS, INCSGMOQ—Change: not yet available0—
Scilex Holding CoSCLX, SCLXW2.06Down −0.03 (−1.44%) since 28 Oct0—
Scinai Immunotherapeutics Ltd.SCNI0.52Down −0.02 (−2.92%) since 28 Oct0—
Scribe Therapeutics, Inc.SCTX17.44Down −0.10 (−0.57%) since 28 Oct0—
Senti Biosciences Holdings, Inc.SNTI0.22Unchanged 0.00 (+0.88%) since 28 Oct0—
Silexion Therapeutics CorpSLXN, SLXNW0.14Down −0.01 (−7.11%) since 28 Oct0—
SL Science Holding LtdSLBT1.17Down −0.04 (−3.31%) since 28 Oct0—
Surrozen, Inc.SRZN29.46Down −0.89 (−2.93%) since 28 Oct0—
SUTRO BIOPHARMA, INC.STRO9.14Down −0.15 (−1.61%) since 28 Oct0—
Taysha Gene Therapies, Inc.TSHA4.22Down −0.01 (−0.24%) since 28 Oct0—
Tectonic Therapeutic, Inc.TECX20.50Down −0.06 (−0.29%) since 28 Oct0—
Tenaya Therapeutics, Inc.TNYA0.40Down −0.01 (−1.34%) since 28 Oct0—
Tevogen Inc.TVGN, TVGNW6.05Down −0.19 (−3.04%) since 28 Oct0—
TRex Bio, Inc.TRXB13.52Down −0.91 (−6.31%) since 28 Oct0—
Twist Bioscience CorpTWST173.45Unchanged 0.00 (0.00%) since 28 Oct0—
Vaxart, Inc.VXRT—Change: not yet available0—
Vericel CorpVCEL42.91Up +1.82 (+4.43%) since 28 Oct0—
Viskase Holdings, Inc.VISK—Change: not yet available0—
VITASPRING BIOMEDICAL CO. LTD.VSBC—Change: not yet available0—
VivoSim Labs, INC.VIVS0.16Up +0.01 (+8.24%) since 28 Oct0—
Voyager Therapeutics, Inc.VYGR1.76Down −0.08 (−4.35%) since 28 Oct0—
WEED, INC.BUDZ—Change: not yet available0—
WINDTREE THERAPEUTICS INCWINT—Change: not yet available0—
X4 Pharmaceuticals, IncXFOR3.36Up +0.01 (+0.30%) since 28 Oct0—
Zeo ScientifiX, Inc.ZEOX—Change: not yet available0—
Zivo Bioscience, Inc.ZIVO—Change: not yet available0—
Zura Bio LtdZURA3.85Down −0.50 (−11.49%) since 28 Oct0—

Companies are placed by SEC Standard Industrial Classification (SIC) code from data.sec.gov submissions.

Biotechnology news

  1. CJ BIO presentará soluciones de nutrición animal orientadas al futuro en EuroTier 2026 (opens in a new tab)

    CJ BIO via PR Newswire

    "Feed Intelligence for Sustainable Performance" FRANKFURT, Alemania, 1 de noviembre de 2026 /PRNewswire/ -- CJ BIO participará en EuroTier 2026, que se celebrará del 10 al 13 de noviembre de 2026 en Hannover, Alemania, para presentar sus soluciones de nutrición animal a clientes y socios...

    Comments on CJ BIO presentará soluciones de nutrición animal orientadas al futuro en EuroTier 2026
  2. CJ BIO präsentiert zukunftsorientierte Lösungen für die Tierernährung auf der EuroTier 2026 (opens in a new tab)

    CJ BIO via PR Newswire

    „Feed Intelligence for Sustainable Performance" FRANKFURT, Deutschland, 1. November 2026 /PRNewswire/ -- CJ BIO wird an der EuroTier 2026 teilnehmen, die vom 10. bis 13. November 2026 in Hannover stattfindet, um interessierten Kunden und Branchenpartnern seine Lösungen für die...

    Comments on CJ BIO präsentiert zukunftsorientierte Lösungen für die Tierernährung auf der EuroTier 2026
  3. CJ BIO to Showcase Future-Ready Animal Nutrition Solutions at EuroTier 2026 (opens in a new tab)

    CJ BIO via PR Newswire

    "Feed Intelligence for Sustainable Performance," FRANKFURT, Germany, Nov. 1, 2026 /PRNewswire/ -- CJ BIO will participate in EuroTier 2026, taking place from November 10 to 13, 2026, in Hanover, Germany, to present its animal nutrition solutions to global customers and industry partners....

    Comments on CJ BIO to Showcase Future-Ready Animal Nutrition Solutions at EuroTier 2026
  4. CJ BIO présentera ses solutions d'avenir pour la nutrition animale à EuroTier 2026 (opens in a new tab)

    CJ BIO via PR Newswire

    "Feed Intelligence for Sustainable Performance" FRANCFORT, Allemagne, 1er novembre 2026 /PRNewswire/ -- CJ BIO participera à EuroTier 2026, qui se tiendra du 10 au 13 novembre 2026 à Hanovre, en Allemagne, afin de présenter ses solutions de nutrition animale à ses clients et partenaires...

    Comments on CJ BIO présentera ses solutions d'avenir pour la nutrition animale à EuroTier 2026
  5. Zhimeng Biopharma has completed the patients enrollment of its investigational drug, CB03-154, in the pivotal Phase 2/3 ALS clinical trial. (opens in a new tab)

    Shanghai Zhimeng Biopharma Inc. via PR Newswire

    SHANGHAI, Oct. 31, 2026 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ( "Zhimeng Biopharma") announced today that its independently developed next-generation potassium channel opener, CB03-154, intended for the treatment of amyotrophic lateral sclerosis (ALS), has successfully...

    Comments on Zhimeng Biopharma has completed the patients enrollment of its investigational drug, CB03-154, in the pivotal Phase 2/3 ALS clinical trial.
  6. aphranel® accueille des médecins européens en Chine pour des échanges cliniques (opens in a new tab)

    Aphranel® via PR Newswire

    Un programme d'une semaine intitulé The Norns' Weave examine la pratique clinique chinoise et ses applications potentielles en Europe SHANGHAI, 30 octobre 2026 /PRNewswire/ -- aphranel®, la marque d'esthétique régénérative de MOYOM Biotech, a lancé un programme d'échange clinique amenant...

    Comments on aphranel® accueille des médecins européens en Chine pour des échanges cliniques
  7. Medicilon udeľuje spoločnosti Revolution Medicines „Cenu za vynikajúce partnerstvo s klientom" (opens in a new tab)

    Medicilon Inc. via PR Newswire

    BOSTON, 30. októbra 2026 /PRNewswire/ – Dr. Yang Liu, riaditeľ oddelenia medicínskej chémie v spoločnosti Revolution Medicines, Inc., a Dr. Kristof Pota, vedúci vedecký pracovník, navštívili výskumné a vývojové centrum Nanhui spoločnosti Medicilon. Privítali ich Dr. Maosheng Duan,...

    Comments on Medicilon udeľuje spoločnosti Revolution Medicines „Cenu za vynikajúce partnerstvo s klientom"
  8. Medicilon представляет революционные лекарства с наградой Excellence in Client Partnership Award (opens in a new tab)

    Medicilon Inc. via PR Newswire

    БОСТОН, 30 октября 2026 г. /PRNewswire/ -- Д-р Ян Лю (Yang Liu), директор по медицинской химии компании Revolution Medicines, Inc. и д-р Кристоф Пота (Kristof Pota), старший научный сотрудник, посетили Научно-исследовательский центр Medicilon в Наньхуэе. Д-р Маошэн Дуань (Maosheng Duan),...

    Comments on Medicilon представляет революционные лекарства с наградой Excellence in Client Partnership Award